Venus Medtech Hangzhou Inc (2500)

Currency in HKD
4.43
+0.46(+11.59%)
Closed·
2500 Scorecard
Full Analysis
Net income is expected to grow this year
Unusual trading volume
2500 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.984.45
52 wk Range
1.595.62
Key Statistics
Bid/Ask
4.41 / 4.43
Prev. Close
3.97
Open
4
Day's Range
3.98-4.45
52 wk Range
1.59-5.62
Volume
10.58M
Average Volume (3m)
4.37M
1-Year Change
-29.36%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2500 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Venus Medtech Hangzhou Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Venus Medtech Hangzhou Inc Company Profile

Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally. The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, VenusA-Pro, and VenusA-Deluxe; and VenusP-Valve, a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis. It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension. In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter. Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.

Compare 2500 to Peers and Sector

Metrics to compare
2500
Peers
Sector
Relationship
P/E Ratio
−2.4x−25.7x−0.5x
PEG Ratio
1.500.030.00
Price/Book
0.8x2.4x2.6x
Price / LTM Sales
3.7x6.7x3.3x
Upside (Analyst Target)
203.7%2.6%43.3%
Fair Value Upside
Unlock−10.6%6.9%Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-1.16 / --
Revenue / Forecast
240.11M / --
EPS Revisions
Last 90 days

2500 Income Statement

FAQ

What Stock Exchange Does Venus Medtech Hangzhou Inc Trade On?

Venus Medtech Hangzhou Inc is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Venus Medtech Hangzhou Inc?

The stock symbol for Venus Medtech Hangzhou Inc is "2500."

What Is the Venus Medtech Hangzhou Inc Market Cap?

As of today, Venus Medtech Hangzhou Inc market cap is 1.75B.

What Is Venus Medtech Hangzhou Inc's Earnings Per Share (TTM)?

The Venus Medtech Hangzhou Inc EPS (TTM) is -1.63.

From a Technical Analysis Perspective, Is 2500 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Venus Medtech Hangzhou Inc Stock Split?

Venus Medtech Hangzhou Inc has split 0 times.

How Many Employees Does Venus Medtech Hangzhou Inc Have?

Venus Medtech Hangzhou Inc has 691 employees.

What is the current trading status of Venus Medtech Hangzhou Inc (2500)?

As of 11 Aug 2025, Venus Medtech Hangzhou Inc (2500) is trading at a price of 4.43, with a previous close of 3.97. The stock has fluctuated within a day range of 3.98 to 4.45, while its 52-week range spans from 1.59 to 5.62.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.